The tick-borne encephalitis virus (TBEV)

Clinical trials for The tick-borne encephalitis virus (TBEV) explained in plain language.

Never miss a new study

Get alerted when new The tick-borne encephalitis virus (TBEV) trials appear

Sign up with your email to follow new studies for The tick-borne encephalitis virus (TBEV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New antibody shot could shield against Tick-Borne brain virus

Prevention Not yet recruiting

This early-stage study tests a lab-made antibody called TBE025 in 18 healthy adults aged 18 to 55. The goal is to see if it is safe and how the body processes it when given through a vein. Participants receive one dose and are closely monitored for side effects. This research hel…

Matched conditions: THE TICK-BORNE ENCEPHALITIS VIRUS (TBEV)

Phase 1 • Sponsor: Giuseppe Pantaleo • Aim: Prevention

Last updated Jun 27, 2026 09:00 UTC

The tick-borne encephalitis virus (TBEV)

Get alerted when new The tick-borne encephalitis virus (TBEV) trials appear

New antibody shot could shield against Tick-Borne brain virus